Published in Nature on July 22, 1976
Antiviral activity of interferons. Bacteriol Rev (1977) 2.25
Regulation of cell proliferation and differentiation by interferons. Biochem J (1985) 1.75
Interferon effects on microfilament organization, cellular fibronectin distribution, and cell motility in human fibroblasts. J Cell Biol (1980) 1.65
Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon. Proc Natl Acad Sci U S A (1980) 1.20
Genetic analysis of the role of cAMP in mediating effects of interferon. Proc Natl Acad Sci U S A (1982) 1.01
Effect of interferon on concentrations of cyclic nucleotides in cultured cells. Proc Natl Acad Sci U S A (1979) 0.94
Specificity of interferon action in protein synthesis. J Virol (1978) 0.93
Biochemical analysis of mutants of a macrophage cell line resistant to the growth-inhibitory activity of interferon. J Cell Biol (1984) 0.90
Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures. Proc Natl Acad Sci U S A (1983) 0.90
Production of high levels of human leukocyte interferon from a continuous human myeloblast cell culture. Antimicrob Agents Chemother (1981) 0.84
Antiviral therapy. Yale J Biol Med (1978) 0.81
Intramuscular and/or intralumbar postexposure treatment of rabies virus-infected cynomolgus monkeys with human interferon. Infect Immun (1979) 0.80
Regulation of macrophage growth and antiviral activity by interferon-gamma. J Cell Biol (1989) 0.80
Ernest (Pete) Knight Jr. (1932-2013). A remembrance to a great interferon scientist and colleague. J Interferon Cytokine Res (2013) 0.75
Multiple biological activities of homogeneous human alpha interferon. Infect Immun (1981) 0.75
Utility of interferons in clinical radiotherapy. J Natl Med Assoc (1982) 0.75
ATP-dependent reduction of azide and HCN by N2-fixing enzymes of Azotobacter vinelandii and Clostridium pasteurianum. Biochim Biophys Acta (1967) 5.81
Transcriptional induction of two genes in human cells by beta interferon. Proc Natl Acad Sci U S A (1984) 4.84
Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61
Characterization of a new low molecular weight RNA in HeLa cell ribosomes. J Mol Biol (1968) 4.44
Reduction of N2O by biological N2-fixing systems. Biochem Biophys Res Commun (1966) 3.66
Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence. Science (1980) 2.77
Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A (1996) 2.45
Interferon: purification and initial characterization from human diploid cells. Proc Natl Acad Sci U S A (1976) 2.45
Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J Biol Chem (1986) 2.37
Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc Natl Acad Sci U S A (1985) 2.24
Fibroblast interferon induces synthesis of four proteins in human fibroblast cells. Proc Natl Acad Sci U S A (1979) 2.01
Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J (2000) 2.01
In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol (1996) 1.98
Distribution of 5 s RNA in HeLa cells. J Mol Biol (1967) 1.78
An energy-dependent hydrogen-evolution from dithionite in nitrogen-fixing extracts of Clostridium pasteurianum. Biochem Biophys Res Commun (1965) 1.77
Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J Biol Chem (1984) 1.74
Selective reduction of c-myc mRNA in Daudi cells by human beta interferon. Proc Natl Acad Sci U S A (1984) 1.65
Heterogeneity of purified mouse interferons. J Biol Chem (1975) 1.61
Support, mutual aid and recovery from dual diagnosis. Community Ment Health J (2000) 1.61
A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol (1991) 1.47
A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal Biochem (1997) 1.47
Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci (1998) 1.34
Clumsiness in children--do they grow out of it? A 10-year follow-up study. Dev Med Child Neurol (1991) 1.29
Recovery challenges among dually diagnosed individuals. J Subst Abuse Treat (2000) 1.24
Isolation and characteristics of flavodoxin from nitrogen-fixing Clostridium pasteurianum. J Biol Chem (1966) 1.23
Consumers as peer specialists on intensive case management teams: impact on client outcomes. Psychiatr Serv (1995) 1.22
Human fibroblast interferon. An improved purification. J Biol Chem (1981) 1.18
In vivo and in vitro synthesis of human rhinovirus type 2 ribonucleic acid. J Virol (1972) 1.18
A cell surface alteration in mouse L cells induced by interferon. Biochem Biophys Res Commun (1977) 1.18
Orthopaedic intervention in early rheumatoid arthritis. Occurrence and predictive factors in an inception cohort of 1064 patients followed for 5 years. Rheumatology (Oxford) (2004) 1.16
Proceedings: Aortic valve replacement using fresh unstented homografts. Thoraxchir Vask Chir (1973) 1.11
Flavodoxin: a flavoprotein with ferredoxin activity from Clostrium pasteurianum. Biochim Biophys Acta (1966) 1.08
Flavodoxin. Chemical and biological properties. J Biol Chem (1967) 0.97
Chronic nutmeg psychosis. J R Soc Med (1993) 0.97
Orthodeoxia: a new finding in interstitial fibrosis. Am Rev Respir Dis (1987) 0.94
The use of "fresh" unstented homograft valves for replacement of the aortic valve: analysis of 6 1/2 years experience. Circulation (1977) 0.93
Oral anticoagulation in atrial fibrillation: A pan-European patient survey. Eur J Intern Med (2007) 0.93
Mitochondria-associated ribonucleic acid of the HeLa cell. Effect of ethidium bromide on the synthesis of ribosomal and 4S ribonucleic acid. Biochemistry (1969) 0.91
Coronary angiography Review of 1500 consecutive cases. Br Heart J (1976) 0.90
Fatal hypercalcaemia complicating carcinoma of breast, resistant to cortisone and phosphate administration. Br Med J (1967) 0.88
Interferon-Sepharose: induction of the antiviral state. Biochem Biophys Res Commun (1974) 0.87
Human interferon-beta: effects of deglycosylation. J Interferon Res (1982) 0.87
Preparation of 125iodine-labelled human fibroblast interferon. J Gen Virol (1978) 0.85
X-ray studies on phospholipid bilayers. II. Polymorphic forms of dipalmitoyl phosphatidylethanolamine. Z Naturforsch C (1983) 0.84
A 15-kD interferon-induced protein and its 17-kD precursor: expression in Escherichia coli, purification, and characterization. J Interferon Res (1989) 0.83
Managed care: recovery enhancer or inhibitor? Psychiatr Serv (2001) 0.83
Vascular access for cancer chemotherapy. JAMA (1977) 0.83
Comparison of doxorubicin with cycloleucine in the treatment of sarcomas. Cancer Treat Rep (1981) 0.83
Interferon-beta enhances the synthesis of a 20,000-dalton membrane protein: a correlation with the cessation of cell growth. J Interferon Res (1985) 0.83
Aortic valve replacement using fresh unstented homografts. Br Heart J (1973) 0.81
Impact of gavage dosing procedure and gastric content on adverse respiratory effects and mortality in rat toxicity studies. J Appl Toxicol (2010) 0.81
Interferons and the regulation of oncogenes. Interferon (1986) 0.79
Proceedings: Coronary angiography using Judkins method. Br Heart J (1974) 0.78
Transurethral resection of the prostate: still the gold standard. Aust N Z J Surg (1997) 0.78
Production and characterization of recombinant mouse brain-derived neurotrophic factor and rat neurotrophin-3 expressed in insect cells. J Neurochem (1994) 0.78
Proceedings: Late results of mitral valve replacement using "fresh" unstented aortic homografts. Thoraxchir Vask Chir (1973) 0.77
Antibodies to synthetic peptides of human interferon-beta. Use in biosynthetic studies. J Biol Chem (1984) 0.77
Interferon: effect on the saturation density to which mouse cells will grow in vitro. J Cell Biol (1973) 0.76
Stimulation of Pyrophosphatase Activity in Clostridium pasteurianum by Reductants. J Bacteriol (1965) 0.75
Transfer RNA: A comparison by gel electrophoresis of the tRNA in HeLa cytoplasm, HeLa mitochondrial fraction, and E. coli. Proc Natl Acad Sci U S A (1969) 0.75
Turnover of HeLa ribosomal RNA. The characterization of a class of RNA in HeLa cytoplasm derived from 28S RNA. J Cell Biol (1971) 0.75
Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271). Cancer Chemother Rep (1975) 0.75
An interferon-induced 16-kD protein is present in the membranes of interferon-sensitive but not in interferon-resistant mouse cells. J Interferon Res (1991) 0.75
Regulation of c-myc RNA and its proteins in Daudi cells by interferon-beta. J Interferon Res (1987) 0.75
A Welch-type test for homogeneity of contrasts under heteroscedasticity with application to meta-analysis. Stat Med (2004) 0.75
In vivo radiolabeling of human IFN-beta. Methods Enzymol (1986) 0.75
A growth inhibitory protein secreted by human diploid fibroblasts. Partial purification and characterization. J Biol Chem (1987) 0.75
Considerations in our search for interferons for clinical use. Adv Exp Med Biol (1978) 0.75
[Counseling of unmarried, teenage expectant mothers]. Taehan Kanho (1965) 0.75
Ribosomal RNA associated with HeLa mitochondria. Biochim Biophys Acta (1969) 0.75
Hepatic responses to edible gums during refeeding of starved rats. J Nutr (1988) 0.75
Fused pyrrolo[2,3-c]carbazol-6-ones: novel immunostimulants that enhance human interferon-gamma activity. J Med Chem (1997) 0.75
THE APPLICATION OF FUNGI AS STYPTICS. Br Med J (1913) 0.75
Patents and literature. Appl Biochem Biotechnol (1981) 0.75
Purification of human fibroblast interferon prepared in the absence of serum. Methods Enzymol (1981) 0.75
Characterization of radioactive human fibroblast-derived beta interferon synthesized in vivo. J Interferon Res (1981) 0.75
Late results of direct myocardial revascularisation. Thoraxchir Vask Chir (1974) 0.75
E. coli transfer RNA: fractionation by electrophoresis on polyacrylamide gel. Prep Biochem (1971) 0.75
Interferon-sepharose: priming of L cells for induction of interferon by MM virus. J Gen Virol (1974) 0.75
Radioisotopes labeling of interferons. Tex Rep Biol Med (1983) 0.75
Claiming disability benefits. Health Visit (1992) 0.75
Acute nephropathy induced by gold sodium thiomalate: alterations in renal heme metabolism and morphology. Toxicol Appl Pharmacol (1987) 0.75
Effects of caffeine on cardiorespiratory function and glucose metabolism during rest and graded exercise. J Sports Med Phys Fitness (1987) 0.75
Left ventricular aneurysm: current appraisal. Br Heart J (1973) 0.75
Proceedings: A new development in ultrasound, using a multi-transducer technique. Br Heart J (1974) 0.75
Vascular access for cancer chemotherapy. Cancer (1979) 0.75
Postcardiac catheterization time-in-bed study: enhancing patient comfort through nursing research. Appl Nurs Res (1994) 0.75
A membrane protein from IFN-beta-treated Daudi cells causes a cessation in cell growth. Biochem Biophys Res Commun (1987) 0.75
Effects of salicylamide and protein restriction on the skeletal development of the rat fetus. Teratology (1978) 0.75
Dry eye therapy: evaluation of current directions and clinical trials. Adv Exp Med Biol (1994) 0.75
Effect of salicylamide on the placental transfer and fetal tissue distribution of sodium-35S-sulfate in the rat. J Nutr (1978) 0.75